{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T03:51:46Z","timestamp":1780890706539,"version":"3.54.1"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:00:00Z","timestamp":1687737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:00:00Z","timestamp":1687737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s40265-023-01914-4","type":"journal-article","created":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T10:01:55Z","timestamp":1687773715000},"page":"1027-1038","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Effectiveness of Non-Budesonide Therapies in Management of Microscopic Colitis: A Systematic Review and Meta-analysis"],"prefix":"10.1007","volume":"83","author":[{"given":"Amalie","family":"Rehde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8298-2807","authenticated-orcid":false,"given":"Sebastian Kj\u00e6rgaard","family":"Hendel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8456-5364","authenticated-orcid":false,"given":"Carsten Bogh","family":"Juhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6037-2883","authenticated-orcid":false,"given":"John","family":"Gubatan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4612-8635","authenticated-orcid":false,"given":"Ole Haagen","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,26]]},"reference":[{"key":"1914_CR1","doi-asserted-by":"publisher","first-page":"227","DOI":"10.5009\/gnl17061","volume":"12","author":"N Gentile","year":"2018","unstructured":"Gentile N, Yen EF. Prevalence, pathogenesis, diagnosis, and management of microscopic colitis. Gut Liver. 2018;12:227\u201335.","journal-title":"Gut Liver."},{"key":"1914_CR2","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.79397","volume":"11","author":"OH Nielsen","year":"2022","unstructured":"Nielsen OH, Fern\u00e1ndez-Ba\u00f1ares F, Sato T, et al. Microscopic colitis: etiopathology, diagnosis, and rational management. Elife. 2022;11: e79397.","journal-title":"Elife"},{"key":"1914_CR3","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1016\/S0140-6736(04)17518-1","volume":"364","author":"OH Nielsen","year":"2004","unstructured":"Nielsen OH, Vainer B, Schaffalitzky de Muckadell OB. Microscopic colitis: a missed diagnosis? Lancet. 2004;364:2055\u20137.","journal-title":"Lancet"},{"key":"1914_CR4","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1093\/ecco-jcc\/jjaa108","volume":"14","author":"P Weimers","year":"2020","unstructured":"Weimers P, Ankersen DV, Lophaven S, et al. Incidence and prevalence of microscopic colitis between 2001 and 2016: a Danish nationwide cohort study. J Crohns Colitis. 2020;14:1717\u201323.","journal-title":"J Crohns Colitis"},{"key":"1914_CR5","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1111\/jocn.14916","volume":"28","author":"KP Lesnovska","year":"2019","unstructured":"Lesnovska KP, M\u00fcnch A, Hjortswang H. Microscopic colitis: struggling with an invisible disabling disease. J Clin Nurs. 2019;28:3408\u201315.","journal-title":"J Clin Nurs"},{"key":"1914_CR6","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1111\/j.1365-2036.2006.02913.x","volume":"23","author":"N Nyhlin","year":"2006","unstructured":"Nyhlin N, Bohr J, Eriksson S, et al. Systematic review: microscopic colitis. Aliment Pharmacol Ther. 2006;23:1525\u201334.","journal-title":"Aliment Pharmacol Ther"},{"key":"1914_CR7","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3109\/00365521.2014.940378","volume":"50","author":"OK Bonderup","year":"2015","unstructured":"Bonderup OK, Wigh T, Nielsen GL, et al. The epidemiology of microscopic colitis: a 10-year pathology-based nationwide Danish cohort study. Scand J Gastroenterol. 2015;50:393\u20138.","journal-title":"Scand J Gastroenterol"},{"key":"1914_CR8","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.cgh.2011.06.005","volume":"9","author":"MJ Stewart","year":"2011","unstructured":"Stewart MJ, Seow CH, Storr MA. Prednisolone and budesonide for short- and long-term treatment of microscopic colitis: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2011;9:881\u201390.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1914_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/ajg.2014.431","volume":"110","author":"J Tong","year":"2015","unstructured":"Tong J, Zheng Q, Zhang C, et al. Incidence, prevalence, and temporal trends of microscopic colitis: a systematic review and meta-analysis. Am J Gastroenterol. 2015;110:265\u201376.","journal-title":"Am J Gastroenterol"},{"key":"1914_CR10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.dld.2014.09.019","volume":"47","author":"BPM Verhaegh","year":"2015","unstructured":"Verhaegh BPM, Jonkers DMAE, Driessen A, et al. Incidence of microscopic colitis in the Netherlands. A nationwide population-based study from 2000 to 2012. Dig Liver Dis. 2015;47:30\u20136.","journal-title":"Dig Liver Dis"},{"key":"1914_CR11","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1016\/j.cgh.2020.10.015","volume":"19","author":"H Maye","year":"2021","unstructured":"Maye H, Safroneeva E, Godat S, et al. Increasing incidence of microscopic colitis in a population-based cohort study in Switzerland. Clin Gastroenterol Hepatol. 2021;19:2205\u20136.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1914_CR12","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.cgh.2021.06.027","volume":"20","author":"J Tome","year":"2022","unstructured":"Tome J, Sehgal K, Kamboj AK, et al. The epidemiology of microscopic colitis in Olmsted County, Minnesota: population-based study from 2011 to 2019. Clin Gastroenterol Hepatol. 2022;20:1085\u201394.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1914_CR13","first-page":"CD003575","volume":"11","author":"TS Kafil","year":"2017","unstructured":"Kafil TS, Nguyen TM, Patton PH, et al. Interventions for treating collagenous colitis. Cochrane Database Syst Rev. 2017;11:CD003575.","journal-title":"Cochrane Database Syst Rev"},{"key":"1914_CR14","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1097\/MEG.0000000000001456","volume":"31","author":"S Sebastian","year":"2019","unstructured":"Sebastian S, Wilhelm A, Jessica L, et al. Budesonide treatment for microscopic colitis: systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2019;31:919\u201327.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1914_CR15","doi-asserted-by":"crossref","unstructured":"Chande N, Al Yatama N, Bhanji T, et al. Interventions for treating lymphocytic colitis. Cochrane Database Syst Rev. 2017;(7):CD006096.","DOI":"10.1002\/14651858.CD006096.pub4"},{"key":"1914_CR16","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/MCG.0000000000001496","volume":"56","author":"MJ Northcutt","year":"2022","unstructured":"Northcutt MJ, Gentile NM, Goldstein JL, et al. Bile acid sequestrant therapy in microscopic colitis. J Clin Gastroenterol. 2022;56:161\u20135.","journal-title":"J Clin Gastroenterol"},{"issue":"Suppl","key":"1914_CR17","first-page":"145","volume":"96","author":"L Ooms","year":"1984","unstructured":"Ooms L, Degryse A, Janssen P. Mechanisms of action of loperamide. Scand J Gastroenterol. 1984;96(Suppl):145\u201355.","journal-title":"Scand J Gastroenterol"},{"key":"1914_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1053\/j.gastro.2015.11.006","volume":"150","author":"DS Pardi","year":"2016","unstructured":"Pardi DS, Tremaine WJ, Carrasco-Labra A. American Gastroenterological Association Institute technical review on the medical management of microscopic colitis. Gastroenterology. 2016;150:247\u201374.","journal-title":"Gastroenterology"},{"key":"1914_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/2050640620951905","volume":"9","author":"S Miehlke","year":"2021","unstructured":"Miehlke S, Guagnozzi D, Zabana Y, et al. European guidelines on microscopic colitis: United European Eastroenterology and European Microscopic Colitis Group statements and recommendations. United Eur Gastroenterol J. 2021;9:13\u201337.","journal-title":"United Eur Gastroenterol J."},{"key":"1914_CR20","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1053\/j.gastro.2015.11.008","volume":"150","author":"GC Nguyen","year":"2016","unstructured":"Nguyen GC, Smalley WE, Vege SS, et al. Clinical Guidelines Committee. American Gastroenterological Association Institute guideline on the medical management of microscopic colitis. Gastroenterology. 2016;150:242\u20136.","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"1914_CR21","doi-asserted-by":"publisher","first-page":"S491","DOI":"10.1093\/ecco-jcc\/jjx180.879","volume":"12","author":"S Miehlke","year":"2018","unstructured":"Miehlke S, Aust D, Mihaly E, et al. Oral once daily budesonide granules rapidly induce clinical remission in lymphocytic colitis: a double-blind, double-dummy, multi-centre, randomised trial. J Crohns Colitis. 2018;12(Suppl 1):S491.","journal-title":"J Crohns Colitis"},{"key":"1914_CR22","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/ajg.2012.416","volume":"108","author":"NM Gentile","year":"2013","unstructured":"Gentile NM, Abdalla AA, Khanna S, et al. Outcomes of patients with microscopic colitis treated with corticosteroids: a population-based study. Am J Gastroenterol. 2013;108:256\u20139.","journal-title":"Am J Gastroenterol"},{"key":"1914_CR23","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/j.1365-2796.1991.tb00372.x","volume":"229","author":"H Sloth","year":"1991","unstructured":"Sloth H, Bisgaard C, Grove A. Collagenous colitis: a prospective trial of prednisolone in six patients. J Intern Med. 1991;229:443\u20136.","journal-title":"J Intern Med"},{"key":"1914_CR24","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/apt.14133","volume":"46","author":"TG Cotter","year":"2017","unstructured":"Cotter TG, Kamboj AK, Hicks SB, et al. Immune modulator therapy for microscopic colitis in a case series of 73 patients. Aliment Pharmacol Ther. 2017;46:169\u201374.","journal-title":"Aliment Pharmacol Ther"},{"key":"1914_CR25","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1002\/ibd.20977","volume":"15","author":"H Hjortswang","year":"2009","unstructured":"Hjortswang H, Tysk C, Bohr J, et al. Defining clinical criteria for clinical remission and disease activity in collagenous colitis. Inflamm Bowel Dis. 2009;15:1875\u201381.","journal-title":"Inflamm Bowel Dis"},{"key":"1914_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2049-3258-72-39","volume":"72","author":"VN Nyaga","year":"2014","unstructured":"Nyaga VN, Arbyn M, Aerts M. Metaprop: a Stata command to perform meta-analysis of binomial data. Arch Public Health. 2014;72:1\u201310.","journal-title":"Arch Public Health"},{"key":"1914_CR27","volume-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analysis","author":"G Wells","year":"2021","unstructured":"Wells G, Shea B, O\u2019Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analysis. Ottawa: Hospital Research Institute; 2021."},{"issue":"1","key":"1914_CR28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jrsm.1411","volume":"12","author":"L McGuinness","year":"2021","unstructured":"McGuinness L, Higgins J. Risk-of-bias VISualization (robvis): an R package and shiny web app for visualizing risk-of-bias assessments. Res Syn Meth. 2021;12(1):55\u201361.","journal-title":"Res Syn Meth."},{"key":"1914_CR29","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/00042737-200104000-00027","volume":"13","author":"B Soussan","year":"2001","unstructured":"Soussan B, Savoye G, Lemoine F, et al. Azathioprine as treatment of refractory lymphocytic colitis. Eur J Gastroenterol Hepatol. 2001;13:457\u20138.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1914_CR30","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1053\/gast.2001.23976","volume":"120","author":"DS Pardi","year":"2001","unstructured":"Pardi DS, Loftus EV Jr, Tremaine WJ, et al. Treatment of refractory microscopic colitis with azathioprine and 6-mercaptopurine. Gastroenterology. 2001;120:1483\u20134.","journal-title":"Gastroenterology"},{"key":"1914_CR31","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1111\/j.1572-0241.2001.04145.x","volume":"96","author":"SR Vennamaneni","year":"2001","unstructured":"Vennamaneni SR, Bonner GF. Use of azathioprine or 6-mercaptopurine for treatment of steroid-dependent lymphocytic and collagenous colitis. Am J Gastroenterol. 2001;96:2798\u20139.","journal-title":"Am J Gastroenterol"},{"key":"1914_CR32","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1111\/apt.12261","volume":"37","author":"A M\u00fcnch","year":"2013","unstructured":"M\u00fcnch A, Fern\u00e1ndez-Ba\u00f1ares F, Munck LK. Azathioprine and mercaptopurine in the management of patients with chronic, active microscopic colitis. Aliment Pharmacol Ther. 2013;37:795\u20138.","journal-title":"Aliment Pharmacol Ther"},{"key":"1914_CR33","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1111\/j.1572-0241.2002.07030.x","volume":"97","author":"DS Pardi","year":"2002","unstructured":"Pardi DS, Ramnath VR, Loftus EV Jr, et al. Lymphocytic colitis: clinical features, treatment, and outcomes. Am J Gastroenterol. 2002;97:2829\u201333.","journal-title":"Am J Gastroenterol"},{"key":"1914_CR34","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1111\/j.1365-2036.2011.04865.x","volume":"34","author":"C Bj\u00f8rnbak","year":"2011","unstructured":"Bj\u00f8rnbak C, Engel PJH, Nielsen PL, et al. Microscopic colitis: clinical findings, topography and persistence of histopathological subgroups. Aliment Pharmacol Ther. 2011;34:1225\u201334.","journal-title":"Aliment Pharmacol Ther"},{"key":"1914_CR35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0016-5085(98)70629-8","volume":"114","author":"KD Fine","year":"1998","unstructured":"Fine KD, Lee EL. Efficacy of open-label bismuth subsalicylate for the treatment of microscopic colitis. Gastroenterology. 1998;114:29\u201336.","journal-title":"Gastroenterology"},{"key":"1914_CR36","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.3109\/00365521.2015.1050692","volume":"50","author":"D Colussi","year":"2015","unstructured":"Colussi D, Salari B, Stewart KO, et al. Clinical characteristics and patterns and predictors of response to therapy in collagenous and lymphocytic colitis. Scand J Gastroenterol. 2015;50:1382\u20138.","journal-title":"Scand J Gastroenterol"},{"issue":"Suppl","key":"1914_CR37","doi-asserted-by":"publisher","first-page":"S483","DOI":"10.1016\/S0016-5085(15)31624-3","volume":"148","author":"NM Gentile","year":"2015","unstructured":"Gentile NM, Khanna S, Loftus EV Jr, et al. Outcomes of patients with microscopic colitis treated with bismuth subsalicylate. Gastroenterology. 2015;148(Suppl):S483.","journal-title":"Gastroenterology"},{"key":"1914_CR38","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.1007\/s10620-021-07162-4","volume":"67","author":"AK Kamboj","year":"2022","unstructured":"Kamboj AK, McGoldrick J, Voth E, et al. Clinical characteristics and treatment response in microscopic colitis based on age at diagnosis: a multicenter retrospective study. Dig Dis Sci. 2022;67:3108\u201314.","journal-title":"Dig Dis Sci"},{"key":"1914_CR39","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1023\/A:1005584810298","volume":"45","author":"R Amaro","year":"2000","unstructured":"Amaro R, Poniecka A, Rogers AI. Collagenous colitis treated successfully with bismuth subsalicylate. Dig Dis Sci. 2000;45:1447\u201350.","journal-title":"Dig Dis Sci"},{"issue":"Suppl","key":"1914_CR40","first-page":"A880","volume":"116","author":"K Fine","year":"1999","unstructured":"Fine K, Ogunji F, Lee E, et al. Randomized double-blind placebo-controlled trial of bismuth subsalicylate for microscopic colitis. Gastroenterology. 1999;116(Suppl):A880.","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"1914_CR41","first-page":"S56","volume":"112","author":"R Tariq","year":"2017","unstructured":"Tariq R, Gentile N, Loftus EV Jr, et al. Outcomes of bismuth subsalicylate treatment in patients with microscopic colitis. Am J Gastroenterol. 2017;112(Suppl 1):S56.","journal-title":"Am J Gastroenterol"},{"key":"1914_CR42","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1136\/gut.2003.023440","volume":"53","author":"M Olesen","year":"2004","unstructured":"Olesen M, Eriksson S, Bohr J, et al. Lymphocytic colitis: a retrospective clinical study of 199 Swedish patients. Gut. 2004;53:536\u201341.","journal-title":"Gut"},{"key":"1914_CR43","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1136\/gut.39.6.846","volume":"39","author":"J Bohr","year":"1996","unstructured":"Bohr J, Tysk C, Eriksson S, et al. Collagenous colitis: a retrospective study of clinical presentation and treatment in 163 patients. Gut. 1996;39:846\u201351.","journal-title":"Gut"},{"key":"1914_CR44","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/j.1572-0241.2003.07225.x","volume":"98","author":"F Fern\u00e1ndez-Ba\u00f1ares","year":"2003","unstructured":"Fern\u00e1ndez-Ba\u00f1ares F, Salas A, Esteve M, et al. Collagenous and lymphocytic colitis: evaluation of clinical and histological features, response to treatment, and long-term follow-up. Am J Gastroenterol. 2003;98:340\u20137.","journal-title":"Am J Gastroenterol"},{"key":"1914_CR45","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1136\/gut.46.2.170","volume":"46","author":"KA Ung","year":"2000","unstructured":"Ung KA, Gillberg R, Kilander A, et al. Role of bile acids and bile acid binding agents in patients with collagenous colitis. Gut. 2000;46:170\u20135.","journal-title":"Gut"},{"issue":"Suppl 1","key":"1914_CR46","doi-asserted-by":"publisher","first-page":"S1163","DOI":"10.1016\/S0016-5085(20)33581-2","volume":"158","author":"S Saha","year":"2020","unstructured":"Saha S, Loftus EV Jr, Tremaine WJ, et al. Bile acid malabsorption and outcomes after treatment with colesevelam in microscopic colitis. Gastroenterology. 2020;158(Suppl 1):S1163-1164.","journal-title":"Gastroenterology"},{"key":"1914_CR47","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.ejim.2009.03.004","volume":"20","author":"P Jobse","year":"2009","unstructured":"Jobse P, Flens MJ, Loffeld RJLF. Collagenous colitis: description of a single centre series of 83 patients. Eur J Intern Med. 2009;20:499\u2013502.","journal-title":"Eur J Intern Med"},{"key":"1914_CR48","first-page":"1","volume":"2015","author":"AHL Yau","year":"2015","unstructured":"Yau AHL, Xiong W, Ko HH. Collagenous enterocolitis manifesting as watery diarrhoea and iron-deficiency anaemia. BMJ Case Rep. 2015;2015:1\u20133.","journal-title":"BMJ Case Rep"},{"issue":"Suppl 1","key":"1914_CR49","first-page":"A663","volume":"136","author":"E Rodriguez","year":"2009","unstructured":"Rodriguez E, Mahadevan U. Anti-TNF therapy for refractory microscopic colitis. Gastroenterology. 2009;136(Suppl 1):A663.","journal-title":"Gastroenterology"},{"key":"1914_CR50","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1177\/2050640619871750","volume":"7","author":"N Daferera","year":"2019","unstructured":"Daferera N, Hjortswang H, Ignatova S, et al. Single-centre experience with anti-tumour necrosis factor treatment in budesonide-refractory microscopic colitis patients. United Eur Gastroenterol J. 2019;7:1234\u201340.","journal-title":"United Eur Gastroenterol J."},{"issue":"Suppl 2","key":"1914_CR51","first-page":"S14","volume":"115","author":"S Gupta","year":"2020","unstructured":"Gupta S, Hurtado J, Marcus J, et al. Utilization of biologic therapy in patients with microscopic colitis not responding to standard therapy. Am J Gastroenterol. 2020;115(Suppl 2):S14.","journal-title":"Am J Gastroenterol"},{"issue":"Suppl","key":"1914_CR52","doi-asserted-by":"publisher","first-page":"S443","DOI":"10.14309\/01.ajg.0000777268.31131.4c","volume":"116","author":"C Choi","year":"2021","unstructured":"Choi C, Neto MBB, Chedid V, et al. The use of biologics in patients with refractory microscopic colitis: a single center experience. Am J Gastroenterol. 2021;116(Suppl):S443-444.","journal-title":"Am J Gastroenterol"},{"issue":"Suppl","key":"1914_CR53","first-page":"Su1355","volume":"164","author":"P Santiago","year":"2023","unstructured":"Santiago P, Pardi R, Braga-Neto M, et al. Use of biological therapy in patients with refractory microscopic colitis. Gastroenterology. 2023;164(Suppl):Su1355.","journal-title":"Gastroenterology"},{"issue":"Suppl","key":"1914_CR54","doi-asserted-by":"publisher","first-page":"S1154","DOI":"10.14309\/01.ajg.0000597784.76385.ea","volume":"114","author":"S Abughazaleh","year":"2019","unstructured":"Abughazaleh S, Glassner K, Wilhite A, et al. A stellar case of Stelara in the treatment of lymphocytic colitis. Am J Gastroenterol. 2019;114(Suppl):S1154.","journal-title":"Am J Gastroenterol"},{"key":"1914_CR55","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1093\/ecco-jcc\/jjac089","volume":"16","author":"G Boivineau","year":"2022","unstructured":"Boivineau G, Zallot C, Zerbib F, et al. Biologic therapy for budesonide-refractory, -dependent or -intolerant microscopic colitis: a multicentre cohort study from the GETAID. J Crohns Colitis. 2022;16:1816\u201324.","journal-title":"J Crohns Colitis"},{"key":"1914_CR56","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1093\/ecco-jcc\/jjy169","volume":"13","author":"P Rivi\u00e8re","year":"2019","unstructured":"Rivi\u00e8re P, M\u00fcnch A, Michetti P, et al. Vedolizumab in refractory microscopic colitis: an international case series. J Crohns Colitis. 2019;13:337\u201340.","journal-title":"J Crohns Colitis"},{"issue":"Suppl 1","key":"1914_CR57","first-page":"Su1354","volume":"164","author":"L Shipley","year":"2023","unstructured":"Shipley L, Hollier J, Ravi S, et al. Vedolizumab in refractory microscopic colitis: long-term outcomes. A single center prospective case series. Gastroenterology. 2023;164(Suppl 1):Sunday 1354.","journal-title":"Gastroenterology"},{"key":"1914_CR58","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.cgh.2009.12.010","volume":"8","author":"G Aram","year":"2010","unstructured":"Aram G, Bayless TM, Chen ZM, et al. Refractory lymphocytic enterocolitis and tumor necrosis factor antagonist therapy. Clin Gastroenterol Hepatol. 2010;8:391\u20134.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1914_CR59","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.crohns.2011.05.001","volume":"5","author":"M Esteve","year":"2011","unstructured":"Esteve M, Mahadevan U, Sainz E, et al. Efficacy of anti-TNF therapies in refractory severe microscopic colitis. J Crohns Colitis. 2011;5:612\u20138.","journal-title":"J Crohns Colitis"},{"key":"1914_CR60","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3109\/00365521.2011.639079","volume":"47","author":"A M\u00fcnch","year":"2012","unstructured":"M\u00fcnch A, Ignatova S, Str\u00f6m M. Adalimumab in budesonide and methotrexate refractory collagenous colitis. Scand J Gastroenterol. 2012;47:59\u201363.","journal-title":"Scand J Gastroenterol"},{"key":"1914_CR61","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/ajg.2013.43","volume":"108","author":"S Pola","year":"2013","unstructured":"Pola S, Fahmy M, Evans E, et al. Successful use of infliximab in the treatment of corticosteroid dependent collagenous colitis. Am J Gastroenterol. 2013;108:857\u20138.","journal-title":"Am J Gastroenterol"},{"key":"1914_CR62","doi-asserted-by":"crossref","unstructured":"Anderson RJ, Makins R. Successful use of adalimumab in patient with treatment-refractory microscopic colitis. BMJ Case Rep. 2016:bcr2016215639.","DOI":"10.1136\/bcr-2016-215639"},{"issue":"Suppl","key":"1914_CR63","doi-asserted-by":"publisher","first-page":"S823","DOI":"10.14309\/01.ajg.0000595476.73729.f6","volume":"114","author":"C Perry","year":"2019","unstructured":"Perry C, Pekez M, Kudaravalli P, et al. Vedolizumab-induced remission of refractory microscopic colitis: a single institution case series. Am J Gastroenterol. 2019;114(Suppl):S823.","journal-title":"Am J Gastroenterol"},{"key":"1914_CR64","doi-asserted-by":"publisher","first-page":"E97","DOI":"10.1093\/ibd\/izz042","volume":"25","author":"JJ Jennings","year":"2019","unstructured":"Jennings JJ, Charabaty A. Vedolizumab-induced remission in 3 patients with refractory microscopic colitis: a tertiary care center case series. Inflamm Bowel Dis. 2019;25:E97.","journal-title":"Inflamm Bowel Dis"},{"key":"1914_CR65","unstructured":"Hodges J, Darden FK, Hale L. The use of infliximab in treatment refractory collagenous colitis: a case report. In: 15th Annual Symposium on Graduate Research and Scholarly Projojects, Wichata State University; 2019."},{"issue":"Suppl","key":"1914_CR66","first-page":"S7","volume":"113","author":"G Samuel","year":"2018","unstructured":"Samuel G, LeStrange A, Charabaty A. Vedolizumab for the treatment of refractory microscopic colitis. Am J Gastroenterol. 2018;113(Suppl):S7.","journal-title":"Am J Gastroenterol"},{"key":"1914_CR67","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.dld.2018.07.013","volume":"50","author":"M Casper","year":"2018","unstructured":"Casper M, Zimmer V, H\u00fcbschen U, et al. Vedolizumab for refractory collagenous colitis: another piece of the puzzle. Dig Liver Dis. 2018;50:1099\u2013100.","journal-title":"Dig Liver Dis"},{"key":"1914_CR68","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/ajg.2018.7","volume":"113","author":"KC Cushing","year":"2018","unstructured":"Cushing KC, Mino-Kenudson M, Garber J, et al. Vedolizumab as a novel treatment for refractory collagenous colitis: a case report. Am J Gastroenterol. 2018;113:632\u20133.","journal-title":"Am J Gastroenterol"},{"issue":"Suppl","key":"1914_CR69","first-page":"S6","volume":"113","author":"M Sharp","year":"2018","unstructured":"Sharp M, White B. Novel therapy for collageneous colitis\u2014a case series. Am J Gastroenterol. 2018;113(Suppl):S6.","journal-title":"Am J Gastroenterol"},{"key":"1914_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12883-019-1437-9","volume":"19","author":"C Borbinha","year":"2019","unstructured":"Borbinha C, Serrazina F, Salavisa M, et al. Bismuth encephalopathy\u2014a rare complication of long-standing use of bismuth subsalicylate. BMC Neurol. 2019;19:1\u20135.","journal-title":"BMC Neurol"},{"key":"1914_CR71","doi-asserted-by":"publisher","first-page":"307","DOI":"10.5770\/cgj.21.323","volume":"21","author":"DB Hogan","year":"2018","unstructured":"Hogan DB, Harbidge C, Duncan A. Bismuth toxicity presenting as declining mobility and falls. Can Geriatr J. 2018;21:307\u20139.","journal-title":"Can Geriatr J."},{"key":"1914_CR72","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1056\/NEJMicm2027922","volume":"387","author":"CW Meaden","year":"2022","unstructured":"Meaden CW, Calello DP. Bismuth subsalicylate poisoning. N Engl J Med. 2022;387:2074.","journal-title":"N Engl J Med"},{"key":"1914_CR73","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s40262-015-0316-9","volume":"55","author":"M Coskun","year":"2016","unstructured":"Coskun M, Steenholdt C, de Boer NK, et al. Pharmacology and optimization of thiopurines and methotrexate in inflammatory bowel disease. Clin Pharmacokinet. 2016;55:257\u201374.","journal-title":"Clin Pharmacokinet"},{"key":"1914_CR74","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/MOG.0000000000000607","volume":"36","author":"NSF Queiroz","year":"2020","unstructured":"Queiroz NSF, Regueiro M. Safety considerations with biologic and new inflammatory bowel disease therapies. Curr Opin Gastroenterol. 2020;36:257\u201364.","journal-title":"Curr Opin Gastroenterol"}],"container-title":["Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-023-01914-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40265-023-01914-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-023-01914-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T10:43:38Z","timestamp":1688553818000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40265-023-01914-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,26]]},"references-count":74,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["1914"],"URL":"https:\/\/doi.org\/10.1007\/s40265-023-01914-4","relation":{},"ISSN":["0012-6667","1179-1950"],"issn-type":[{"value":"0012-6667","type":"print"},{"value":"1179-1950","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,26]]},"assertion":[{"value":"12 June 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study did not receive any funding.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Amalie Rehde, Sebastian Kj\u00e6rgaard Hendel, Carsten Bogh Juhl, John Gubatan, and Ole Haagen Nielsen declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Interested readers may request study materials from the authors.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"AR: Data curation: equal; investigation: equal; project administration: equal; writing\u2014original draft: lead). SKH: Data curation: lead; formal analysis: equal; investigation: equal; validation: equal; writing\u2014review and editing: lead). CBJ: Data curation: equal; formal analysis: lead; software: lead; supervision: equal; validation: lead; writing\u2014review and editing: equal). JG: Data curation: equal; investigation: equal; methodology: equal; supervision: equal; writing\u2014review and editing: equal. OHN: Conceptualization: lead; data curation: equal; formal analysis: equal; investigation: lead; project administration: lead; software: equal; supervision: lead; validation: equal; writing\u2014review and editing: lead).","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}